UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weigh
Finance

UK's FTSE 100 slips as losses in energy stocks and AstraZeneca weigh

Published by Global Banking & Finance Review

Posted on May 1, 2026

2 min read

· Last updated: May 1, 2026

Add as preferred source on Google

FTSE 100 Closes Lower Amid Losses in Energy Stocks and AstraZeneca

Market Overview and Key Movers

May 1 (Reuters) - London's blue-chip FTSE 100 closed slightly lower on Friday, dragged down by losses in heavyweight energy stocks and drugmaker AstraZeneca, while a looming UK public holiday thinned trade.

The blue-chip FTSE 100 index ended 0.1% lower at 10,363.93 points, while the midcap FTSE 250 climbed 0.3%. 

Major Decliners

AstraZeneca

• AstraZeneca shed 3.1% after a U.S. Food and Drug Administration advisory panel voted against recommending an experimental breast cancer treatment the drugmaker has said is central to its long-term growth ambitions.

NatWest

• NatWest reported a 12% rise in first-quarter profit, but its shares fell 3.4% after the lender's non-interest income was 7% below analysts' forecasts.

Energy Stocks

• Heavyweight energy stocks Shell and BP were among the biggest drags on the blue-chip index, tracking weakness in crude oil prices.

Other Market Influences

Geopolitical Developments

• Tehran has submitted its latest proposal for negotiations with the United States, but it is unclear whether it can break a deadlock in efforts to end the Iran war.

Top Gainers

Pearson

• The gainers included Pearson, which rose 3.1% after the education company said demand for its virtual learning products drove a 4% rise in first-quarter underlying group sales.

Unilever and Rolls-Royce

• Consumer staples giant Unilever jumped 2.6% to hit a one-month high, while engineering company Rolls-Royce added 1.5%, extending gains a day after it reiterated its profit outlook.

Diageo

• Spirits maker Diageo ended 0.7% higher. It had risen by as much as 2.8% after U.S. President Donald Trump said he was removing tariffs on UK-made whisky.

Market Sentiment and Trading Volumes

Weekly Performance

• The FTSE 100 clocked marginal weekly declines, taking its consecutive weekly losses to a third after mixed corporate earnings this week hit sentiment.

Trading Volumes

• Trading volumes on London exchanges were well below their 20-day moving average, as most markets across Europe were closed on Friday and Britain has a bank holiday on Monday.

Reporting and Editing

(Reporting by Shashwat Chauhan in Bengaluru; editing by Barbara Lewis)

Key Takeaways

  • FTSE 100 closed 0.1% lower at 10,363.93, FTSE 250 rose 0.3%
  • AstraZeneca fell after an FDA panel rejected its breast cancer drug camizestrant
  • NatWest shares slid despite profit growth due to weaker-than-expected non-interest income

Frequently Asked Questions

Why did the FTSE 100 slip on Friday?
The FTSE 100 slipped 0.1% mainly due to losses in heavyweight energy stocks and AstraZeneca.
What impacted AstraZeneca's share price?
AstraZeneca's shares fell after a US FDA advisory panel voted against recommending its experimental breast cancer treatment.
Which other major companies affected the FTSE 100 performance?
Shell, BP, and NatWest were among the companies pulling the index lower, while Pearson and Unilever gained.
How did trading volume compare to usual levels?
Trading volumes were well below the 20-day moving average due to the public holiday and market closures.
How did the FTSE 250 perform?
The FTSE 250 rose by 0.3% even as the FTSE 100 slipped.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category